TRIPS

This study analyses the policy and developmental implications, for Cambodia, Djibouti, Senegal and Zambia, of losing access to the LDC-specific provisions of the TRIPS Agreement

This paper explores the challenges countries face in negotiating trade and investment agreements that could restrict their ability to manage access to medicines and the public health systems more generally.